IBRX Q1 2026 Earnings EPS Miss as Biotech Continues PreRevenue Advancement NPCE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges SDGR Q1 2026 Earnings Loss Widens Amid Software Transition Stock Rises APAM Q1 2026 Earnings EPS Misses Consensus as Market Headwinds Persist PPTA Q1 2026 Earnings WiderThanExpected Loss Amidst Antimony Project Progress